FilingReader Intelligence
Biocon revenue growth figure corrected to INR164.7bn
July 17, 2025 at 09:10 AM UTC•By FilingReader AI
Biocon Limited reported total income of INR164,699 million for FY25, representing 5% year-over-year growth.
Biosimilars contributed 58% to operational revenue, while Research Services accounted for 23% and Generics 19%.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:BIOCON•Bombay Stock Exchange
News Alerts
Get instant email alerts when Biocon publishes news
Free account required • Unsubscribe anytime